These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
911 related articles for article (PubMed ID: 21769904)
1. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Yang F; Zhang L; Huo XS; Yuan JH; Xu D; Yuan SX; Zhu N; Zhou WP; Yang GS; Wang YZ; Shang JL; Gao CF; Zhang FR; Wang F; Sun SH Hepatology; 2011 Nov; 54(5):1679-89. PubMed ID: 21769904 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma. Yu TT; Xu XM; Hu Y; Deng JJ; Ge W; Han NN; Zhang MX World J Gastroenterol; 2015 Jun; 21(23):7208-17. PubMed ID: 26109807 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma. Ding X; Qi C; Min J; Xu Z; Huang K; Tang H J Cell Mol Med; 2020 Sep; 24(18):10551-10559. PubMed ID: 32729661 [TBL] [Abstract][Full Text] [Related]
7. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
8. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence. Zhang S; Zhong G; He W; Yu H; Huang J; Lin T J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320 [TBL] [Abstract][Full Text] [Related]
9. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker. Zhao X; Liu Y; Yu S Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma. Gong X; Wei W; Chen L; Xia Z; Yu C Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756 [TBL] [Abstract][Full Text] [Related]
14. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
15. Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Chen Y; Lin MC; Yao H; Wang H; Zhang AQ; Yu J; Hui CK; Lau GK; He ML; Sung J; Kung HF Hepatology; 2007 Jul; 46(1):200-8. PubMed ID: 17596871 [TBL] [Abstract][Full Text] [Related]
16. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1. Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition. Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2. Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870 [TBL] [Abstract][Full Text] [Related]
20. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]